The Patent Finder

LA PharmaTech Inc.

15 patents currently held · Updated Nov 19, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Apr 2039
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Sep 26, 2027
    The maintenance fee for Pharmaceutical compositions and methods for anxiety, depression and other psychiatric disorders (US 11,938,139) comes due Sep 26, 2027. Unpaid by Mar 27, 2028, it lapses early.
  • 3 fees due Nov 5, 2027

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,898,493Novel Pharmaceutical Compositions and Methods for Psychiatric Symptoms of Patients with Alzheimer's Disease
In force
 · Medium confidence
In forceMedium confidence
US 10,946,026Pharmaceutical compositions and methods for treating mental, behavioral, cognitive disorders
In force
 · USPTO record
In forceUSPTO record
US 10,966,989Pharmaceutical Compositions and Methods for Treating Mental, Behavioral, Cognitive Disorders
In force
 · High confidence
In forceHigh confidence
US 11,116,773Method of treating dementia
In force
 · USPTO record
In forceUSPTO record
US 11,318,144Compositions and Methods for Treating Alzheimer's Disease and Parkinson's Disease
In force
 · Medium confidence
In forceMedium confidence
US 11,690,849Method of Treating Dementia
In force
 · Low confidence
In forceLow confidence
US 11,744,833Pharmaceutical Compositions and Methods for Treatment of Insomnia
In force
 · Low confidence
In forceLow confidence
US 12,138,269Method of treating dementia
In force
 · USPTO record
In forceUSPTO record
US 10,639,314Method of treating Alzheimer's disease
In force
 · USPTO record
In forceUSPTO record
US 10,639,316Method of treating Parkinson's disease
In force
 · USPTO record
In forceUSPTO record
10 of 15 patents shown.
Pro members see all 15.
Pro members: see all 15 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending · 2 no status recorded

Showing 1 to 3 of 3, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
17/940,533Sep 8, 2022No status recorded
17/546,342Compositions and Methods for Treating Alzheimer's Disease and Parkinson's DiseaseDec 9, 2021Pending
17/094,405Nov 10, 2020No status recorded
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited